Liberty Health Sciences Licenses Aphria’s Solei Brand

Liberty Health Sciences to Bring Solei Cannabis Brand to Florida and Massachusetts

Liberty signs amended licensing agreement with Aphria to include Solei in its growing portfolio of products

TORONTO, May 11, 2018 /PRNewswire/ – Liberty Health Sciences Inc. (CSE: LHS) (OTCQX: LHSIF) (“Liberty” or the “Company”) today announced it has signed an amended licensing agreement with Aphria Inc. (“Aphria”) to add Solei Sungrown Cannabis (“Solei”), to the Company’s growing portfolio of brands. Under the terms of the agreement, Liberty will be able to produce and sell Solei in Florida and Massachusetts, subject to receipt of all required approvals from the Florida Department of Health, Office of Medical Marijuana Use, and from the Commonwealth of Massachusetts, Medical Use of Marijuana Program or the Massachusetts Cannabis Control Commission, if any.

We are incredibly excited to introduce Solei to the U.S. and to make this brand available to our patients throughout Florida, and soon Massachusetts. Solei is the perfect complement to Liberty’s patient-centric approach to medical cannabis. Solei hopes to make medical cannabis understandable to all of our patients in need in an easy-to-understand format.

George Scorsis, Director and CEO of Liberty

Solei will be available in a wide variety of product consumption alternatives, with easy-to-use instructions designed to simplify cannabis use.

Aphria is delighted to extend our strategic relationship with Liberty, as they continue to demonstrate leadership in Florida and soon other legal markets in the U.S. Medical cannabis patients in Florida and elsewhere will benefit from Solei’s uncomplicated and simplified approach to consuming cannabis, which really sets the brand apart in the marketplace.

Vic Neufeld, CEO of Aphria

Liberty’s Cannabis Education Centers will offer Solei alongside the Company’s currently lineup of brands to be offered to patients in Florida, including Aphria, Mary’s Medicinals, incredibles, incredible Extracts, and incredible Wellness. Solei products are expected to be available for sale by the end of July 2018.

About Liberty Health Sciences Inc.

Liberty Health Sciences Inc. is an investor and operator in the medical cannabis market, capitalizing on new and existing opportunities in U.S. states where medical cannabis is legal.  Liberty’s stringent investment criteria for expansion maximizes returns to shareholders, while the company focuses on significant near- and mid-term business opportunities.  Liberty has an extensive background in highly regulated industries, with expertise in becoming a low-cost producer.  The company leverages commercial greenhouse knowledge to deliver high-quality, clean and safe pharmaceutical grade cannabis to patients.

For more information, please visit

Original press release

Get ahead of the crowd by signing up for 420 Investor, the largest & most comprehensive premium subscription service for cannabis traders and investors since 2013.

Published by NCV Newswire
NCV Newswire
The NCV Newswire by New Cannabis Ventures aims to curate high quality content and information about leading cannabis companies to help our readers filter out the noise and to stay on top of the most important cannabis business news. The NCV Newswire is hand-curated by an editor and not automated in anyway. Have a confidential news tip? Get in touch.

Get Our Sunday Newsletter